Featured Research

from universities, journals, and other organizations

Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program

Date:
October 18, 2009
Source:
Hospital for Special Surgery
Summary:
According to a new study most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change.

According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change.

"Lupus patients are battling systemic inflammation, which in itself is a risk factor for cardiovascular disease," said Doruk Erkan, M.D. the program's director and co-director of the Mary Kirkland Center for Lupus Care at Hospital for Special Surgery in New York. "But many of them do not know their risk, so it is extremely important to get counseling to manage risk factors such as smoking, obesity and hypertension, which may help decrease their chances of cardiovascular disease."

Launched in March 2009, the Cardiovascular Disease Prevention Counseling Program for Lupus Patients helps lupus patients think beyond their primary condition and take steps for future wellness. To assess the impact of the program, patients were given satisfaction surveys at the end of their initial visit and asked to rate aspects of the program, including quality of counseling and educational materials, likelihood of recommending the program to others, and improvement in the patient's knowledge about cardiovascular risk. Overall, the results of the survey showed that patients were well satisfied with the free counseling program.

"Out of 27 patients, 25 -- or 93 percent -- have filled out the satisfaction survey," said Virginia Haiduc, M.D, the program's coordinator. "We found that over half of those patients were not aware that lupus was a risk factor for cardiovascular disease. This program educates them about that risk and then helps them begin to decrease other risk factors that they have control over, such as poor diet and lack of physical activity."

Monica Richey, R.N., ANP-BC/GNP-M.S., the program nurse, feels that the counseling not only helps lupus patients change their behaviors and lifestyle, but also extends to those around them. "One young woman who came to our program was 24 years old, morbidly obese and had three kids," Richey said. "The next time she came back, she brought her kids because they were all upset with me. She had gone home and thrown out all the soda, cookies and chips. She was helping the whole family make a change to a healthier lifestyle."

Based on their chart and information gained during the appointment, patients may also be referred to a nutritionist or a physical therapist to help them make changes that will lower their risk for cardiovascular disease. Sotiria Tzakas, M.S., R.D., CDN, from the Nutrition Department and Josephine Park, MSPT, OCS, from the Rehabilitation Department are consultants for the program and co-authors of the abstract being presented.

The authors say that their study highlights that programs designed to help patients understand the cardiovascular risks associated with lupus are very well received by patients. The counseling helps patients increase their knowledge and begin to make behavior changes.

"Physicians should recognize that patients do not understand their cardiovascular risk," said Dr. Erkan. "Educating them about these risks should be considered a part of standard lupus care. We would encourage other hospitals to create similar programs."

As the program continues, Drs. Erkan and Haiduc will also analyze clinical factors to determine whether, in addition to behavioral change, there is a decrease in the prevalence of cardiovascular risk factors in the patients who have undergone counseling.


Story Source:

The above story is based on materials provided by Hospital for Special Surgery. Note: Materials may be edited for content and length.


Cite This Page:

Hospital for Special Surgery. "Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program." ScienceDaily. ScienceDaily, 18 October 2009. <www.sciencedaily.com/releases/2009/10/091018141728.htm>.
Hospital for Special Surgery. (2009, October 18). Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/10/091018141728.htm
Hospital for Special Surgery. "Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program." ScienceDaily. www.sciencedaily.com/releases/2009/10/091018141728.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins